Skip to main content
. 2022 Oct 19;2022:9004830. doi: 10.1155/2022/9004830

Figure 7.

Figure 7

TMB, MSI, and drug sensitivity analyses of cuproptosis-related prognostic signature in breast cancer. (a) Link between the expression of cuproptosis-related prognostic signature and TMB score in breast cancer. (b) Link between the expression of cuproptosis-related prognostic signature and MSI score in breast cancer. (c) Link between the expression of cuproptosis-related prognostic signature and drug sensitivity in breast cancer. TMB: tumor mutation burden; MSI: microsatellite instability.